As of February 2023 MannKind Corp has a market cap of $1.35 Billion. This makes MannKind Corp the world's 4348th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $1.35 B | -2.09% |
2022 | $1.38 B | 26.33% |
2021 | $1.09 B | 48.85% |
2020 | $0.73 B | 169.99% |
2019 | $0.27 B | 37.81% |
2018 | $0.19 B | -28.11% |
2017 | $0.27 B | -9.46% |
2016 | $0.30 B | -51% |
2015 | $0.62 B | -70.65% |
2014 | $2.11 B | 10.24% |
2013 | $1.92 B | 190.71% |
2012 | $0.66 B | 101.23% |
2011 | $0.32 B | -68.12% |
2010 | $1.03 B | 4.03% |
2009 | $0.99 B | 182.98% |
2008 | $0.34 B | -56.64% |
2007 | $0.80 B | -33.29% |
2006 | $1.20 B | 231.67% |
2005 | $0.36 B | -28.51% |
2004 | $0.51 B |
On Feb 6th, 2023 the market cap of MannKind Corp was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $245.63 B | 17,987.03% | ๐บ๐ธ USA |
![]() Novo Nordisk NVO | $310.43 B | 22,758.00% | ๐ฉ๐ฐ Denmark |
![]() Eli Lilly LLY | $320.83 B | 23,524.12% | ๐บ๐ธ USA |
![]() Merck MRK | $263.75 B | 19,321.20% | ๐บ๐ธ USA |
![]() Halozyme Therapeutics HALO | $7.00 B | 416.12% | ๐บ๐ธ USA |
![]() Nektar Therapeutics
NKTR | $0.58 B | -57.24% | ๐บ๐ธ USA |